Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Medicine & Life Sciences

Melanoma
Neoplasms
Therapeutics
Safety
Immunotherapy
Autophagy
Riluzole
Ligands
Clinical Trials
gemcitabine
Oncolytic Viruses
Endometrial Neoplasms
Biomarkers
Pharmacokinetics
Neoplasm Metastasis
Radiotherapy
Mutation
Melanocytes
docetaxel
Carcinogenesis
Hepatitis C
Survival
Hepatitis B
Antibodies
Growth
CTLA-4 Antigen
Skin
Tumor Microenvironment
Arginine
Tumor Burden
Mitogen-Activated Protein Kinases
1-Phosphatidylinositol 4-Kinase
Disease-Free Survival
Brain
Colitis
Merkel Cell Carcinoma
Fatigue
Somatomedin Receptors
pembrolizumab
Cell Death
Interleukin-15
Drug Therapy
Patient Selection
Small Cell Lung Carcinoma
IGF Type 1 Receptor
Preexisting Condition Coverage
Transitional Cell Carcinoma
Phosphatidylinositol 3-Kinases
Carboplatin
Mitogen-Activated Protein Kinase Kinases
Castration
Glutamate Receptors
Confidence Intervals
Renal Cell Carcinoma
Monoclonal Antibodies